Skip to Content
Merck
CN
  • Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.

Synthesis and antibacterial activity of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl)piperazinyl quinolone derivatives.

Bioorganic & medicinal chemistry letters (2005-08-18)
Alireza Foroumadi, Saeed Emami, Abdolreza Hassanzadeh, Majid Rajaee, Kazem Sokhanvar, Mohammad Hassan Moshafi, Abbas Shafiee
ABSTRACT

A series of N-(5-benzylthio-1,3,4-thiadiazol-2-yl) and N-(5-benzylsulfonyl-1,3,4-thiadiazol-2-yl) derivatives of piperazinyl quinolones was synthesized and evaluated for antibacterial activity against Gram-positive and Gram-negative microorganisms. Some of these derivatives exhibit high activity against Gram-positive bacteria; Staphylococcus aureus and Staphylococcus epidermidis, comparable or more potent than their parent N-piperazinyl quinolones norfloxacin and ciprofloxacin as reference drugs. The SAR of this series indicates that both the structure of the benzyl unit and the S or SO(2) linker dramatically impact antibacterial activity.

MATERIALS
Product Number
Brand
Product Description

Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Supelco
Norfloxacin, VETRANAL®, analytical standard